INDUCE-seq: ENSURING THE SAFE DEVELOPMENT OF CELL AND GENE THERAPIES BY GENE EDITING

被引:0
|
作者
Reed, S. H. [1 ,2 ]
Dobbs, F. M. [2 ]
机构
[1] Cardiff Univ, Sch Med, Cardiff, Wales
[2] Broken String Biosci, Cambridge, England
关键词
off-target gene editing; genetic safety; genomic tools;
D O I
暂无
中图分类号
Q813 [细胞工程];
学科分类号
摘要
1141
引用
收藏
页码:E29 / E29
页数:1
相关论文
共 50 条
  • [31] CRISPR gene-editing therapies for hypertrophic cardiomyopathy
    Alanna Strong
    Nature Medicine, 2023, 29 (2) : 305 - 306
  • [32] Discovery and validation of human genomic safe harbor sites for gene and cell therapies
    Aznauryan, Erik
    Yermanos, Alexander
    Kinzina, Elvira
    Devaux, Anna
    Kapetanovic, Edo
    Milanova, Denitsa
    Church, George M.
    Reddy, Sai T.
    CELL REPORTS METHODS, 2022, 2 (01):
  • [33] ENSURING PATIENT ACCESS TO GENE THERAPIES: THE ROLE OF COMPANION DIAGNOSTICS
    Tzaras, D.
    Carr, D.
    VALUE IN HEALTH, 2020, 23 : S419 - S419
  • [35] Preclinical development of an efficient and safe gene editing platform for the treatment of Wiskott Aldrich Syndrome
    Naseem, A.
    Turchiano, G.
    Rai, R.
    Vetharoy, W.
    Whittaker, T. E.
    Thrasher, A. J.
    Cavazza, A.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A202 - A203
  • [36] Applications of Gene Editing and Nanotechnology in Stem Cell-Based Therapies for Human Diseases
    Bolideei, Mansoor
    Barzigar, Rambod
    Gahrouei, Razieh Bahrami
    Mohebbi, Elham
    Haider, Khawaja Husnain
    Paul, Sayan
    Paul, Manash K.
    Mehran, Mohammad Javad
    STEM CELL REVIEWS AND REPORTS, 2025,
  • [37] In silico tools to accelerate process development of cell and gene therapies
    Bort, J. A. Hernandez
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A105 - A105
  • [39] Industrializing cell and gene therapies
    Shanley, Agnes
    Pharmaceutical Technology, 2019, 2019 (04)
  • [40] TRANSLATION OF CELL AND GENE THERAPIES
    Narayanan, G.
    CYTOTHERAPY, 2016, 18 (06) : S23 - S23